Inventor · disambiguated record
Tzehaw Chen
Also filed as: CHEN TZEHAW
15 granted patents·6 pending applications·49 citations·filing 2021–2024
92Inventor score
Technology areasA61K
Top patents by PatentIndex Score
21 records- 0196US11413290B2Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2021·Granted Aug 16, 2022·8 cites·30 claims
- 0296US11324745B2Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2021·Granted May 10, 2022·7 cites·30 claims
- 0396US11298356B1Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2021·Granted Apr 12, 2022·7 cites·30 claims
- 0496US11202778B2Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2021·Granted Dec 21, 2021·9 cites·30 claims
- 0595US11633398B2Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2022·Granted Apr 25, 2023·2 cites·28 claims
- 0695US11389450B2Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2021·Granted Jul 19, 2022·7 cites·28 claims
- 0794US11980619B2Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and usesNANOCOPOEIA LLC·Filed 2022·Granted May 14, 2024·3 cites·18 claims
- 0889US11559485B2Orally disintegrating tablet comprising amorphous solid dispersion of nilotinibNANOCOPOEIA LLC·Filed 2021·Granted Jan 24, 2023·6 cites·30 claims
- 0985US2025032491A1Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2024·Application pending·0 cites
- 1082US12053471B2Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2023·Granted Aug 6, 2024·0 cites·22 claims
- 1182US12016861B2Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2022·Granted Jun 25, 2024·0 cites·22 claims
- 1282US11998548B2Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2022·Granted Jun 4, 2024·0 cites·19 claims
- 1381US12465606B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2022·Granted Nov 11, 2025·0 cites·20 claims
- 1481US12433891B2Amorphous solid dispersions of dasatinib and uses thereofHANDA THERAPEUTICS LLC·Filed 2022·Granted Oct 7, 2025·0 cites·20 claims
- 1580US12029740B2Amorphous nilotinib microparticles and uses thereofNANOCOPOEIA LLC·Filed 2022·Granted Jul 9, 2024·0 cites·24 claims
- 1679US12478625B2Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and usesHANDA THERAPEUTICS LLC·Filed 2024·Granted Nov 25, 2025·0 cites·17 claims
- 1779US2022105035A1Amorphous solid dispersions of dasatinib and uses thereofNANOCOPOEIA LLC·Filed 2021·Application pending·0 cites
- 1870US2023372325A1Amorphous cabozantinib particles and uses thereofNANOCOPOEIA LLC·Filed 2023·Application pending·0 cites
- 1969US2025025463A1Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib and in vitro characterization thereofNANOCOPOEIA LLC·Filed 2024·Application pending·0 cites
- 2064US2023157948A1Orally disintegrating tablet comprising amorphous solid dispersion of nilotinibNANOCOPOEIA LLC·Filed 2023·Application pending·0 cites
- 2162US2022378788A1Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib and in vitro characterization thereofNANOCOPOEIA LLC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tzehaw Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →